PT840604E - Analogos de acidos gordos nao beta-oxidaveis sua utilizacao como medicamentos terapeuticos activos e sua preparacao - Google Patents

Analogos de acidos gordos nao beta-oxidaveis sua utilizacao como medicamentos terapeuticos activos e sua preparacao

Info

Publication number
PT840604E
PT840604E PT95941241T PT95941241T PT840604E PT 840604 E PT840604 E PT 840604E PT 95941241 T PT95941241 T PT 95941241T PT 95941241 T PT95941241 T PT 95941241T PT 840604 E PT840604 E PT 840604E
Authority
PT
Portugal
Prior art keywords
sub
fatty acids
oxidating
analogs
beta
Prior art date
Application number
PT95941241T
Other languages
English (en)
Inventor
Rolf Berge
Jon Songstad
Original Assignee
Rolf Berge
Jon Songstad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolf Berge, Jon Songstad filed Critical Rolf Berge
Publication of PT840604E publication Critical patent/PT840604E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT95941241T 1995-07-14 1995-10-25 Analogos de acidos gordos nao beta-oxidaveis sua utilizacao como medicamentos terapeuticos activos e sua preparacao PT840604E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO952796A NO952796D0 (no) 1995-07-14 1995-07-14 Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater

Publications (1)

Publication Number Publication Date
PT840604E true PT840604E (pt) 2003-01-31

Family

ID=19898394

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95941241T PT840604E (pt) 1995-07-14 1995-10-25 Analogos de acidos gordos nao beta-oxidaveis sua utilizacao como medicamentos terapeuticos activos e sua preparacao

Country Status (13)

Country Link
US (1) US6046237A (pt)
EP (3) EP1232750A1 (pt)
JP (1) JP3553966B2 (pt)
KR (1) KR100394986B1 (pt)
AT (1) ATE224188T1 (pt)
AU (2) AU4272696A (pt)
CA (1) CA2226871A1 (pt)
DE (1) DE69528291T2 (pt)
DK (1) DK0840604T3 (pt)
ES (1) ES2183889T3 (pt)
NO (1) NO952796D0 (pt)
PT (1) PT840604E (pt)
WO (1) WO1997003663A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7240398A (en) * 1998-05-08 1999-11-29 Rolf Berge Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
AU784116B2 (en) * 1999-09-17 2006-02-09 Peplin Biolipids Pty Ltd Anti-cancer nitro- and thia-fatty acids
NO328803B1 (no) * 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
NO20003591L (no) * 2000-07-13 2002-01-14 Thia Medica As Fettsyreanaloger for behandling av kreft
NO20006008L (no) * 2000-11-28 2002-05-29 Thia Medica As Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
US7057057B2 (en) * 2002-05-22 2006-06-06 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) * 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
FR2828487B1 (fr) 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
EP1515978A1 (en) 2002-06-20 2005-03-23 IC Vec Limited Sulfur-containing phospholipid derivatives
WO2004046104A2 (en) * 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
FR2850650B1 (fr) * 2003-01-31 2005-03-25 Genfit S A Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures
FR2850869B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
EP1718602A4 (en) * 2004-01-30 2007-12-12 Peplin Biolipids Pty Ltd THERAPEUTIC AND CARRIER MOLECULES
RU2394598C2 (ru) * 2004-07-19 2010-07-20 Тиа Медика Ас Композиция, содержащая белковый материал и соединения, содержащие неокисляющиеся структурные элементы жирных кислот
AU2005264782B2 (en) * 2004-07-19 2010-12-16 Thia Medica As Composition comprising protein material and non-oxidizable fatty acid entities
US20060160902A1 (en) * 2004-11-08 2006-07-20 Wiech Norbert L Histone deacetylase inhibitors
HK1220606A1 (zh) 2013-03-11 2017-05-12 Nobesita As 包含非可氧化脂肪酸的天然脂类
AU2014228387B2 (en) 2013-03-11 2016-09-01 Sciadonics, Inc. Lipid compositions containing bioactive fatty acids
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2208533A1 (de) * 1972-02-23 1973-09-27 Kolmar Laboratories Neue alkylthioaether
GB8813012D0 (en) * 1988-06-02 1988-07-06 Norsk Hydro As Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals

Also Published As

Publication number Publication date
EP0840604B1 (en) 2002-09-18
ATE224188T1 (de) 2002-10-15
KR100394986B1 (ko) 2004-01-24
JPH11514339A (ja) 1999-12-07
KR19990028993A (ko) 1999-04-15
AU734431B2 (en) 2001-06-14
EP0840604A1 (en) 1998-05-13
US6046237A (en) 2000-04-04
AU4272696A (en) 1997-02-18
WO1997003663A1 (en) 1997-02-06
DE69528291D1 (de) 2002-10-24
DE69528291T2 (de) 2003-05-08
EP1232750A1 (en) 2002-08-21
NO952796D0 (no) 1995-07-14
EP1232749A1 (en) 2002-08-21
DK0840604T3 (da) 2002-12-30
CA2226871A1 (en) 1997-02-06
AU6124300A (en) 2000-11-30
ES2183889T3 (es) 2003-04-01
JP3553966B2 (ja) 2004-08-11

Similar Documents

Publication Publication Date Title
PT840604E (pt) Analogos de acidos gordos nao beta-oxidaveis sua utilizacao como medicamentos terapeuticos activos e sua preparacao
ES2131207T3 (es) Derivados de amidas del acido valproico y 2-valproenoico y su uso como anticonvulsivos.
NO861621L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 9-(2-fosfonylmethoxyethyl)-adenin
GB8813012D0 (en) Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals
NO170280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater
KR830006174A (ko) 기관지 항경련성 화합물 제조방법
FI893750A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista makrosyklistä johdannaista
DE2964059D1 (en) 9-hydroxyalkyl-purines, processes for preparing them and therapeutical composition containing the 9-hydroxyalkyl-purines as active ingredients
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
KR890011838A (ko) 16-데하이드로 비타민d₃-유도체
EP0283151A3 (en) Prostaglandins useful for lowering intraocular pressure
FR2363330A1 (fr) Medicament destine a reduire la fertilite chez les mammiferes
ES2004141A6 (es) Un procedimiento de preparacion de nuevas 1,4-dihidropiridinas
ES8400429A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-piperazino pirimidina.
GR852867B (pt)
DE3371627D1 (en) Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them
FR2440353A1 (fr) Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament
KR920012008A (ko) 페닐알킬아미노알킬 화합물과 이들의 제법 및 이 화합물들을 포함하는 약물
DE3672253D1 (de) Hexensaeuren.
ES8100249A1 (es) Un metodo para la preparacion de un compuesto de acido hi- droxamico
AR245567A1 (es) Composicion para atraer cucarachas.
KR890002202A (ko) 하이드록시-, 알콕시- 및 벤질옥시-치환된 인지질, 이의 제조 방법 및 약제로서의 이의 용도
KR940005279A (ko) 아미딘을 함유하는 약제학적 조성물 및 아미딘
FR2450835A2 (fr) Derives de la tetrahydroalstonine et leur application en therapeutique
KR950702412A (ko) 항 hiv제